Early collaboration pays long-term rewards

You can increase the chances of success in injection molding projects with early involvement of all major stakeholders. The many rewards of early collaboration include:

  • Reduced product development time
  • Optimized part performance
  • Optimized cycle time
  • Lower scrap rate

Join us at Molding 2016

Eastman will be presenting and exhibiting. Molding 2016 is the premier conference focused on innovations in injection molding technology—with information you can’t find anywhere else. That makes it the perfect place to show and tell the unique advantages of Eastman Tritan copolyester.  

Join the Tritan experts Mar. 29 to 31, 2016, to learn how Tritan can improve your processes and end products. 


Some traditional polymers used in drug delivery devices are not compatible with modern oncology chemotherapies—including the cancer drugs and the carrier solvents that help make them effective.
Device manufacturers have more reasons than ever to understand the chemical resistance of the materials they use in devices, including:
•  The widespread use and growing economic importance of oncology drugs
•  A recent FDA Safety Alert* concerning infusion devices made with polycarbonate (PC) or acrylonitrile-butadiene-styrene (ABS)

Tritan for medical-device applications

新医疗级Eastman Tritan™共聚聚酯在医疗器械应用中可在不牺牲性能的情况下确保安全放心。Tritan独特的性能组合,满足了此前医疗器械行业的已有其他聚合物无法达到的多种客户需求。
Expect a balance of important advantages with Eastman Tritan™ copolyester MX711.  
  • Processability
  • 耐化学品性
  • 韧性
  • 水解稳定性
  • Compatibility with sterilization methods
  • 透明度
  • 不含BPA
  • Secondary operations and assembly
  • Heat resistance
Eastman Tritan™ copolyester MX711 is well-suited for medical-device applications that demand superior chemical resistance, clarity and hydrolytic stability, including:
  • IV system components
  • Blood therapy devices
Find more information here about the advantages of Tritan for a wide range medical applications.